Detalhe da pesquisa
1.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol
; 96(5): e29675, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746997
2.
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis.
Helicobacter
; 27(5): e12914, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848363
3.
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan.
J Formos Med Assoc
; 119(11): 1626-1633, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31926791
4.
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
Gastroenterology
; 155(4): 1109-1119, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29964036
5.
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C.
J Formos Med Assoc
; 118(8): 1187-1192, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279502
6.
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial.
J Antimicrob Chemother
; 73(9): 2510-2518, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846605
7.
Computer-aided diagnosis for identifying and delineating early gastric cancers in magnifying narrow-band imaging.
Gastrointest Endosc
; 87(5): 1339-1344, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29225083
8.
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Lancet
; 388(10058): 2355-2365, 2016 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27769562
9.
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials.
J Antimicrob Chemother
; 72(12): 3481-3489, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961996
10.
Sequential therapy for 10â days versus triple therapy for 14â days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial.
Gut
; 65(11): 1784-1792, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26338825
11.
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial.
Am J Gastroenterol
; 111(3): 381-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26832653
12.
Morgagni hernia causing ileus and gastric emphysema.
J Formos Med Assoc
; 120(7): 1533-1534, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773857
13.
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria.
Gut
; 64(10): 1517-28, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25406127
14.
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Lancet
; 381(9862): 205-13, 2013 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23158886
15.
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.
J Antimicrob Chemother
; 68(2): 450-6, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099849
16.
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(3): 228-241, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549320
17.
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.
Lancet Gastroenterol Hepatol
; 8(7): 623-634, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178702
18.
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter.
Int J Colorectal Dis
; 27(3): 337-44, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22006490
19.
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial.
J Antimicrob Chemother
; 66(8): 1847-52, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21632579
20.
Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.
Open Forum Infect Dis
; 7(8): ofaa301, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818142